Grande halle de La Villette, Stand 464
Visitors to the stand will be updated on manufacturing and user advantages made possible with the latest additions to Borealis and Borouge’s portfolio of dedicated Bormed polyolefins for healthcare.
Bormed™ LE6601-PH for the development of transparent, simple to squeeze ampoules
Bormed™ LE6601-PH was spotlighted at Pharmapack 2011 and has since proven itself in the market for eye, ear and nose drop treatment ampoules as well as dip-tubes in pharmaceutical sprays.
Packaging converters benefit from trouble-free conversion on standard blow moulding and blow, fill and seal (BFS) machinery. Wall thickness and ampoule weight are easy to control thanks to Bormed LE6601-PH’s optimised molecular weight distribution that produces material with low swell. This allows difficult shapes to be formed, while ensuring straightforward dosing to simplify production of consistent, high quality ampoules. The easy processing creates less waste and a low energy requirement during extrusion.
High flow Bormed™ HE9601-PH for high speed injection moulding with decreased energy use
This high density polyethylene (HDPE) creates productivity improvements for manufacturers of, for example, two-part syringe plungers, caps and closures, etc. With a melt flow rate (MFR) of 31, Bormed™ HE9601-PH delivers a flow rate improvement of up to 2.5 times that of comparable alternatives. The injection moulding process, in particular of components with complex design parameters or long flow lengths, is simplified. Converters see faster production and increased throughput at decreased pressure and temperature. Energy and mould maintenance requirements are both lowered providing a cost advantage. These benefits are gained without compromising the performance of medical devices and pharmaceutical and diagnostic packaging.
Bormed™ SC820CF for primary and secondary medical pouches
Another Bormed development leading the way in creating new opportunities for improved performance and efficiency in the healthcare market is Bormed™ SC820CF for primary and secondary medical pouches. This random heterophasic polypropylene (PP) copolymer for cast- and blown film applications combines softness with toughness and is steam sterilisable. It also maintains good optical and mechanical properties after retorting.
Bormed SC820CF is intended as a blending component or co-extrusion layer for primary pouches with contents such as intravenous (IV) solutions, nutrition and dialysis fluids. Furthermore it is used as part of the solution for secondary wrap films for dust and vapour barrier and protection. This new material contributes to all PP pouch solutions, which serve as a viable alternative to commonly used glass bottles or polyvinyl chloride (PVC) pouches.
“Our commitment to the healthcare market spans more than three decades and will continue far into the future,” says Rainer Höfling, Borealis Vice President for Business Unit Moulding. “We provide our customers with the utmost confidence when using our dedicated Bormed materials in their applications.”
Bormed ™ – because we care
With more than 30 years of experience in serving the healthcare market, Borealis understands the industry’s need for reliable global material suppliers and is continually strengthening its support.
Borealis offers dedicated global products, security of supply, innovation and technical support for the specialised and strict requirements of these customers. Its ever-expanding range of dedicated Bormed™ polyolefins focuses on high quality and long-term commitment which is anchored by our financially strong ownership. Polypropylene and polyethylene innovations provide superior technical performance to meet the lightweight, aesthetic and processing and consumer convenience-related demands of the fast-growing medical devices and pharmaceutical and diagnostic packaging markets, independent of conversion technology or polymer type.
The Bormed product range responds to the challenging service requirements of the healthcare industry. Regulatory compliance and special production and quality control procedures are some of the elements that ensure stability, reliability, traceability, consistency and continuity. This gives customers around the world confidence in their use of Bormed materials to advance their application.
About Borealis and Borouge
Borealis is a leading provider of chemical and innovative plastics solutions that create value for society. With sales of EUR 6.3 billion in 2010, customers in over 120 countries, and around 5,100 employees worldwide, Borealis is owned 64% by the International Petroleum Investment Company (IPIC) of Abu Dhabi and 36% by OMV, the leading energy group in the European growth belt. Borealis is headquartered in Vienna, Austria, and has production locations, innovation centres and customer service centres across Europe and the Americas.
Through Borouge, a joint venture between Borealis and the Abu Dhabi National Oil Company (ADNOC), one of the world’s major oil and gas companies, the company’s footprint reaches out to the Middle East, Asia Pacific, the Indian sub-continent and Africa. Established in 1998, Borouge employs approximately 1,600 people, has customers in more than 50 countries and its headquarters are in Abu Dhabi in the UAE and Singapore.
Building on Borealis’ unique Borstar® technology and their experience in polyolefins of more than 50 years, Borealis and Borouge provide innovative, value creating plastics solutions for the infrastructure (pipe systems and power and communication cables), automotive and advanced packaging markets. In addition, Borealis offers a wide range of base chemicals from melamine and fertilizer to phenol and acetone.
Today, Borealis and Borouge have a manufacturing capacity of over 5.4 million tonnes of polyolefins (polyethylene and polypropylene) per year having recently completed a 1.5 million tonne capacity expansion in Abu Dhabi. The Borouge 3 plant expansion will be completed at the end of 2013 with a further capacity of 2.5 million tonnes per year (t/y) being fully operational in mid-2014. The companies continue to invest to ensure that their customers throughout the value chain and across the globe can always rely on product quality, consistency and security of supply.
Borouge (borouge.com) and Borealis (borealisgroup.com) are committed to the principles of Responsible Care® and proactively contribute to addressing the world’s water and sanitation challenges through their Water for the World™ (waterfortheworld.net) initiative.
Bormed and Water for the World are trademarks of the Borealis group.
Borstar is a registered trademark of the Borealis group.